Day: February 24, 2026

By bringing Origin AI’s real-time AI sensing platform into the ADT ecosystem, ADT advances proactive, intelligence-driven home protection, and broader smart home use cases BOCA RATON, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT), a leading provider of security, interactive, and smart home solutions serving residential and small business customers in the U.S., today announced it has acquired Origin Wireless, Inc. (d/b/a “Origin AI” and “Origin”), bringing Origin’s AI sensing platform and related intellectual property into the ADT ecosystem.  Origin AI’s sensing technology enables the home to better understand classification of motion and human detection without cameras, audio, or wearable devices. Once integrated into ADT’s platform, these capabilities are expected to enable new customer use cases and safety enhancements by...

MONROE TOWNSHIP, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NYSE American: OPTT), today announced it has received an approximate $1.5 million Purchase Order from the United States Coast Guard (USCG) for the installation and deployment of buoy systems previously ordered. This award completes the acquisition cycle and enables near-term fielding of the systems in support of Department of Homeland Security (DHS) maritime security missions. The Company expects this order to contribute to near-term revenues as installation and deployment activities commence. Under the scope of work, OPT will execute deployment, commissioning, and operational activation to ensure the systems are fully integrated and mission ready. The buoys are expected to enter active service shortly following installation. Jason...

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation, energy security and smart city infrastructure and HEVO Inc., a New York–based leading developer and provider of patented Rezonant™ wireless charging hardware and the Journey™ software platform, today announced the launch of their combined technology solution providing the first integrated autonomous wireless charging system powered by the EV ARC™ off grid, rapidly-deployed, solar-powered EV charging infrastructure product. The system is ideal for the rapidly growing autonomous vehicle (AV) sector and adaptable to a wide range of commercial electric vehicle (EV) fleet applications where charging vehicles without relying on...

PLANO, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced that members of its executive leadership team will participate in the following investor conferences in March:Raymond James 47th Annual Institutional Investors Conference, 11:35 a.m. ET, March 3 Oppenheimer 36th Annual Healthcare MedTech & Services Conference, 12:40 p.m. ET, March 17 KeyBanc Capital Markets Healthcare Forum, 11:15 a.m. ET, March 18A live webcast and replay for each event will be accessible under “News & Events” on the Investor Relations section of Integer’s website at investor.integer.net. Learn more about Integer at www.integer.net. About Integer®Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical...

GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) — Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will feature discussions with leading companies and organizations across the specialty chemicals ecosystem, with an emphasis on industry dynamics, current trends, and business fundamentals, as well as Specialty Chemicals investing. Attendees will also have the opportunity to participate in one-on-one meetings with management teams, available upon request. For those who cannot attend in person, access to the symposium will be available via webcast. Investors should contact their Gabelli relationship manager for more information or click on the registration link below. Prospective attendees can learn more about the symposium on our website. Presenting...

Sravan Emany brings capital markets and commercial-stage, rare disease expertise as the Company advances towards commercialization Andrew Miller adds deep clinical development and product approval experience to support Kyverna’s next phase of growth EMERYVILLE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) — Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today announced the appointments of Sravan K. Emany and Andrew Miller, Ph.D. to its Board of Directors. Mr. Emany will assume the role of Audit Committee Chair, following the transition of Dan Spiegelman from this position, who has stepped down from the Board. “We are pleased to welcome Sravan and Andrew to our Board of Directors at a pivotal moment in Kyverna’s evolution,” said Warner...

Tel Aviv, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) — Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, announced today that Quantum Transportation Ltd. (“Quantum Transportation” or “QT”),- a minority-owned subsidiary of Quantum X Labs Ltd., the Israeli quantum tech group Viewbix is in the process of acquiring, has successfully achieved a key cloud implementation milestone in its transformer-based quantum decoder program. Following the successful initial validation of its prototype and completion of Milestone 1, including securing a key IP license from Ramot at Tel Aviv University, Quantum Transportation has now implemented its transformer-based neural decoder on an AWS cloud. This cloud deployment establishes the necessary infrastructure to process complex quantum...

In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus’ novel serotonergic agonist (“NSA”) portfolioThis news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to it short form base shelf prospectus dated September 17, 2025, as amended on December 19, 2025. NEW YORK and TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) — Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company developing NSAs for serious mental health conditions, today announced the appointment of Dr. Freda Lewis-Hall, DFAPA, MFPM, to its Board of Directors. Dr. Lewis-Hall will also serve as Chair of the Company’s Scientific Advisory Committee. Dr. Lewis-Hall is a pioneering physician...

Announcement no. 3-2026 24 February 2026 The unanimous Board of Directors of North Media and the majority shareholder of North Media, Baunegård ApS, nominates Lasse Ingemann Brodt for election as a new member of the Board of Directors of North Media at the company’s annual general meeting to be held on 10 April 2026. The Board of Directors of North Media is expected to elect Lasse Ingemann Brodt as its new chairman immediately after the annual general meeting. Provided that Lasse Ingemann Brodt is elected to the Board of Directors by the Annual General Meeting, Lasse Ingemann Brodt will at the same time resign from his current position as Group CEO. The nomination follows the announcement in 2025 that the current chairman, Ole Borch, is resigning. See Company Announcements nos. 9-2025 and 12-2025. Lasse Ingemann Brodt has been a member...